JDD Webinars

Differentiating Approach to Acne Therapy: Women Vs. Men

By October 14, 2020April 22nd, 2021No Comments

Featured Article

Differentiating Approach to Acne Therapy: Women vs. Men

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.

FACULTY


Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama

Watch Now

You May Also Like

Journal of Drugs in Dermatology JDD featuring Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact

Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact

| Featured Articles, JDD Re:View, Latest News, Medical Derm, Skin Cancer, Wound | No Comments
Wound Care Is Trending: A JDD Vault Pick on Bensal HP and Repair This is a must-read article from JDD. Wound care is a hot topic in dermatology and that is…

Dermatology Roundup: New Regimen and Label Expansion in Inflammatory Skin Disease Treatments

| Dermatology Roundup, Featured Articles, Latest News | No Comments
The U.S. Food & Drug Administration (FDA) recently adopted changes to the approvals of two medications for inflammatory skin diseases. Ebglyss (lebrikizumab-lbkz) has a newly approved regimen of one maintenance…

From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us

| Featured Articles, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Andrew Blauvelt Not all psoriasis data tell the same story, and sometimes the loudest signal isn't the most important one. In this episode of the JDD Podcast, host…

Leave a Reply